Kalydeco is a Oral Granule in the Human Prescription Drug category. It is labeled and distributed by Vertex Pharmaceuticals Incorporated. The primary component is Ivacaftor.
Product ID | 51167-600_35644d47-5161-4a5e-8c5c-04b0a9a201e5 |
NDC | 51167-600 |
Product Type | Human Prescription Drug |
Proprietary Name | Kalydeco |
Generic Name | Ivacaftor |
Dosage Form | Granule |
Route of Administration | ORAL |
Marketing Start Date | 2019-04-29 |
Marketing Category | NDA / NDA |
Application Number | NDA207925 |
Labeler Name | Vertex Pharmaceuticals Incorporated |
Substance Name | IVACAFTOR |
Active Ingredient Strength | 25 mg/1 |
Pharm Classes | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC],Chloride Channel Activation Potentiators [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2019-04-29 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA207925 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-04-29 |
Ingredient | Strength |
---|---|
IVACAFTOR | 25 mg/1 |
NDC | Brand Name | Generic Name |
---|---|---|
51167-200 | Kalydeco | ivacaftor |
51167-300 | Kalydeco | ivacaftor |
51167-400 | Kalydeco | ivacaftor |
51167-600 | Kalydeco | ivacaftor |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
KALYDECO 85585659 4245428 Live/Registered |
Vertex Pharmaceuticals Incorporated 2012-03-31 |
KALYDECO 85155478 4147369 Live/Registered |
Vertex Pharmaceuticals Incorporated 2010-10-18 |